These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 34590925)
1. Safety of renal biopsy bleeding prophylaxis with desmopressin. Barrios RHS; Burguera Vion V; Álvarez Nadal M; Cintra Cabrera M; Elías Triviño S; Villa Hurtado D; Ortego S; Fernández Lucas M; Rivera-Gorrin M J Int Med Res; 2021 Sep; 49(9):3000605211040764. PubMed ID: 34590925 [TBL] [Abstract][Full Text] [Related]
2. Desmopressin acetate to prevent bleeding in percutaneous kidney biopsy: a systematic review. Lim CC; Tan HZ; Tan CS; Healy H; Choo J; Franca Gois PH Intern Med J; 2021 Apr; 51(4):571-579. PubMed ID: 32040251 [TBL] [Abstract][Full Text] [Related]
3. Bleeding Complications and Adverse Events After Desmopressin Acetate for Percutaneous Renal Transplant Biopsy. Ho QY; Lim CC; Thangaraju S; Siow B; Chin YM; Hao Y; Lee PH; Foo M; Tan CS; Kee T Ann Acad Med Singap; 2020 Feb; 49(2):52-64. PubMed ID: 32246706 [TBL] [Abstract][Full Text] [Related]
4. Desmopressin for the prevention of bleeding in percutaneous kidney biopsy: efficacy and hyponatremia. Lim CC; Siow B; Choo JCJ; Chawla M; Chin YM; Kee T; Lee PH; Foo M; Tan CS Int Urol Nephrol; 2019 Jun; 51(6):995-1004. PubMed ID: 31028561 [TBL] [Abstract][Full Text] [Related]
5. Desmopressin (Octostim®) before a native kidney biopsy can reduce the risk for biopsy complications in patients with impaired renal function: A pilot study. Peters B; Hadimeri H; Mölne J; Nasic S; Jensen G; Stegmayr B Nephrology (Carlton); 2018 Apr; 23(4):366-370. PubMed ID: 28107603 [TBL] [Abstract][Full Text] [Related]
6. Renal transplant biopsy complications: assessment of risk factors and potential of desmopressin to decrease risk of hemorrhage. Peters B; Nasic S; Jensen G; Stegmayr B Acta Radiol; 2020 Dec; 61(12):1717-1723. PubMed ID: 32212828 [TBL] [Abstract][Full Text] [Related]
7. Assessment and validation of a defined fluid restriction protocol in the use of subcutaneous desmopressin for children with inherited bleeding disorders. Mason JA; Robertson JD; McCosker J; Williams BA; Brown SA Haemophilia; 2016 Sep; 22(5):700-5. PubMed ID: 27385253 [TBL] [Abstract][Full Text] [Related]
8. Retrospective Assessment of Desmopressin Effectiveness and Safety in Patients With Antiplatelet-Associated Intracranial Hemorrhage. Feldman EA; Meola G; Zyck S; Miller CD; Krishnamurthy S; Cwikla GM; Darko W; Jennings S; Sullivan R; Seabury R Crit Care Med; 2019 Dec; 47(12):1759-1765. PubMed ID: 31567345 [TBL] [Abstract][Full Text] [Related]
9. Hyponatremia after desmopressin (DDAVP) use in pediatric patients with bleeding disorders undergoing surgeries. Sharma R; Stein D J Pediatr Hematol Oncol; 2014 Aug; 36(6):e371-5. PubMed ID: 24942016 [TBL] [Abstract][Full Text] [Related]
11. Desmopressin and bleeding risk after percutaneous kidney biopsy. Athavale A; Kulkarni H; Arslan CD; Hart P BMC Nephrol; 2019 Nov; 20(1):413. PubMed ID: 31730448 [TBL] [Abstract][Full Text] [Related]
12. PFA-100 test in the detection of platelet dysfunction and monitoring DDAVP in a patient with liver cirrhosis undergoing inguinal hernia repair. Vucelić D; Golubović M; Bjelović M Srp Arh Celok Lek; 2012; 140(11-12):782-5. PubMed ID: 23350257 [TBL] [Abstract][Full Text] [Related]
13. Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders. Leissinger C; Carcao M; Gill JC; Journeycake J; Singleton T; Valentino L Haemophilia; 2014 Mar; 20(2):158-67. PubMed ID: 23937614 [TBL] [Abstract][Full Text] [Related]
14. Pre-procedure desmopressin acetate to reduce bleeding in renal failure: does it really work? Radhakrishnan S; Chanchlani R; Connolly B; Langlois V Nephron Clin Pract; 2014; 128(1-2):45-8. PubMed ID: 25373723 [TBL] [Abstract][Full Text] [Related]
15. A systematic review: The use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. Trigg DE; Stergiotou I; Peitsidis P; Kadir RA Haemophilia; 2012 Jan; 18(1):25-33. PubMed ID: 21624012 [TBL] [Abstract][Full Text] [Related]
16. Intranasal desmopressin reduces renal biopsy-related bleeding and serum sodium levels in patients with reduced renal function. Rao NS; Chandra A Clin Kidney J; 2020 Dec; 13(6):1063-1067. PubMed ID: 33391750 [TBL] [Abstract][Full Text] [Related]
17. Administration of the vasopressin analog desmopressin for the management of bleeding in rectal cancer patients: results of a phase I/II trial. Iseas S; Roca EL; O'Connor JM; Eleta M; Sanchez-Luceros A; Di Leo D; Tinelli M; Fara ML; Spitzer E; Demarco IA; Ripoll GV; Pifano M; Garona J; Alonso DF Invest New Drugs; 2020 Oct; 38(5):1580-1587. PubMed ID: 32166534 [TBL] [Abstract][Full Text] [Related]
18. Desmopressin use prior to renal transplant biopsy-does it fit? Anandagoda N; Jayawardene S; Macdougall IC; Shah S Clin Kidney J; 2014 Dec; 7(6):602-4. PubMed ID: 25859381 [TBL] [Abstract][Full Text] [Related]
19. Intranasal desmopressin (Octim): a safe and efficacious treatment option for children with bleeding disorders. Khair K; Baker K; Mathias M; Burgess C; Liesner R Haemophilia; 2007 Sep; 13(5):548-51. PubMed ID: 17880442 [TBL] [Abstract][Full Text] [Related]
20. Desmopressin-related myocardial infarction in a patient with Wegener's granulomatosis: a case report and review of the literature. Pape E; Béné J; Buchdahl AL; Gautier S; Hatron PY; Lambert M J Mal Vasc; 2013 Feb; 38(1):43-6. PubMed ID: 23265678 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]